MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 15:09 Uhr</div>[url=https://moodylab.smhs.gwu.edu/lab-members]Zoya Demidenko[/url]: Scientist in Tumor Biology [url=https://www.aging-us.com/article/100406/]Zoya Demidenko[/url] is a prominent researcher connected with the Unit of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, developing a strong base in life science research. Her academic work covers multiple critical fields, among them the PI3K/AKT/mTOR molecular pathway, cell cycle regulation, biological aging, and tumor science. Currently, she has authored more than 46 peer-reviewed articles, which have accumulated upwards of 4,100 mentions — a reflection to the impact of her work. Among her key contributions involves elucidating the processes of cellular senescence. Her research showed that when the cell cycle is halted yet cellular expansion persists, cells enter senescence. Crucially, [url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P]Zoya Demidenko[/url] established that this process is controlled with drugs using agents such as mTOR inhibitors. [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko]Zoya Demidenko[/url] has also contributed substantially to cancer treatment research, notably in the domain of selective cell protection — a strategy intended to protecting normal tissue from anticancer drugs while leaving tumor cells susceptible. This method holds significant potential for reducing the toxic effects of cancer treatment. Across her professional journey, Demidenko has worked with prominent scientists worldwide, among them Dr. Mikhail Blagosklonny. Her publications can be found in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: Possessing an h-index of 33, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord]Zoya Demidenko[/url] ranks as a widely cited voice in current cancer research, with her discoveries continue to influence our knowledge of the way biological cells grow old, resist therapy, and how malignant disease may be better targeted. https://www.sciencedirect.com/science/article/abs/pii/037811199400784P</blockquote><br> Abbrechen
